文献速递类风湿关节炎其他结缔组织病

四种心血管风险量表在慢性炎性风湿病患者中的表现:10年随访数据

Performance of four cardiovascular risk scales in chronic inflammatory rheumatic disease patients: 10-year follow-up data.
PubMed 文献 · Rheumatology (Oxford) · 2025-01-01

西班牙CARMA项目纳入67家医院2080例无既往心血管事件的慢性炎性风湿病患者,随访10年,8.4%(174例)发生首次心血管事件。四种量表均与心血管事件强相关,QRISK3拟合更优且对整体队列准确估计10年风险,PREVENT-CVD对整体队列及类风湿关节炎患者均表现可靠,SCORE2与PREVENT-ASCVD低估风险。

要点

  • 2080例CIRD患者10年随访中8.4%(174例)发生首次心血管事件。
  • 四种量表均与心血管事件强相关,QRISK3拟合更优,但其他量表与实际事件一致性更高。
  • QRISK3与PREVENT-CVD准确估计整体队列10年风险;SCORE2与PREVENT-ASCVD低估风险。

核心结论

  • 所有量表均能有效区分低与高心血管风险,PREVENT-CVD是评估CIRD患者心血管风险的有价值工具。

研究设计与样本

  • 研究纳入西班牙67家医院2010-2012年无既往心血管事件的慢性炎性风湿病患者,随访10年,通过病历、患者/家属联系或西班牙国家统计研究所收集数据。
  • 采用按炎性疾病校正的Cox回归模型分析心血管风险,使用AIC、BIC及Gönen和Heller's K评估模型表现。

主要发现

  • 2080例患者中8.4%(174例)发生首次心血管事件,发生事件者年龄更大、病程更长、体重指数更高且高血压、糖尿病或高胆固醇血症更常见。
  • 四种量表均与心血管事件强相关,风险比从QRISK3的1.04(95%CI:1.03,1.05)到SCORE2的1.13(95%CI:1.11,1.16)。
  • QRISK3拟合更优(AIC/BIC更低),但其他量表与实际事件一致性更高。
  • QRISK3与PREVENT-CVD准确估计整体队列10年心血管风险,SCORE2与PREVENT-ASCVD低估风险。
  • 在类风湿关节炎患者中,QRISK3高估风险,PREVENT-CVD是唯一表现可靠的量表。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare the performance of QRESEARCH risk estimator (QRISK)3, Systematic Coronary Risk Evaluation (SCORE)2, Predicting Risk of cardiovascular disease EVENTs (PREVENT)-cardiovascular disease (CVD) and PREVENT-atherosclerotic cardiovascular disease (ASCVD) equations in predicting cardiovascular (CV) risk among individuals with chronic inflammatory rheumatic diseases (CIRD) enrolled in the Spanish CARMA project. METHODS: The study included CIRD patients from 67 Spanish hospitals (2010-2012) without prior CV events. After a 10-year follow-up, data were collected through medical records, patient/family contact or the Spanish National Statistics Institute. CV risk was analysed using Cox regression models adjusted for inflammatory disease. Model performance was evaluated using AIC, BIC, and Gönen and Heller's K. RESULTS: Among 2080 patients, 8.4% (174) experienced a first CV event. Those with CV events were older, had longer disease duration, higher body mass index and more frequent hypertension, diabetes or hypercholesterolemia. All four scales were strongly associated with CV events, with hazard ratios ranging from 1.04 (95% confidence interval [CI]: 1.03, 1.05) for QRISK3 to 1.13 (95% CI: 1.11, 1.16) for SCORE2. QRISK3 demonstrated better adjustment (lower AIC/BIC) but other scales showed higher concordance with actual events. QRISK3 and PREVENT-CVD accurately estimated 10-year CV risk for the overall cohort, while SCORE2 and PREVENT-ASCVD underestimated risk. Among rheumatoid arthritis patients, QRISK3 overestimated risk, whereas PREVENT-CVD was the only scale to perform reliably. CONCLUSIONS: All scales effectively distinguished between low and high CV risk. PREVENT-CVD emerges as a valuable tool for assessing CV risk in CIRD patients.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Llorca J, Castañeda S, Ferraz-Amaro I, et al. Performance of four cardiovascular risk scales in chronic inflammatory rheumatic disease patients: 10-year follow-up data. Rheumatology (Oxford). 2025. PMID: 40170224. doi:10.1093/rheumatology/keaf168

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。